Results 31 to 40 of about 2,274 (85)
Graves病患者血清可溶性白细胞介素2受体水平与甲状腺激素的关系
比较Graves病患者血清可溶性白细胞介素2受体(sIL-2R)水平及其与甲状腺素(T4)、三碘甲腺原氨酸(T3)和促甲状腺激素(TSH)等水平的相关性。结果显示:甲状腺机能亢进症未治疗组血清sIL-2R明显升高;12例Graves病患者经抗甲状腺药物治疗后sIL-2R明显降低;Graves眼病经治疗临床甲亢症状缓解组血清sIL-2R无明显改变;血清sIL-2R与T3、T4呈正相关,与TSH呈负相关。提示除了自身免疫功能紊乱外,甲状腺激素水平可能对Graves病患者血清sIL-2R水平起重要的调节作用。
doaj
1临床资料患者,女性,54岁,因“行走不稳、言语笨拙1周”于2022年6月来本院就诊。1周前无明显诱因出现行走不稳、言语笨拙,一过性眩晕,可在他人搀扶下行走,言语笨拙类似吟诗样。既往否认饮酒史、特殊药物及毒物服用史;家族中无类似疾病病史。神经系统查体:意识水平及意识内容正常,无失语,小脑性语言,概测视野正常,双侧水平眼震,四肢肌力正常、肌张力略降低,共济失调步态,双侧指鼻试验不稳准,双侧快速轮替试验笨拙,双侧跟膝胫试验欠稳准,昂白氏征睁眼及闭眼均不稳准,左侧病理征阳性可疑,余体格检查未见明显异常。
于乐 +4 more
doaj
[Resistance to thyroid hormone syndrome with developmental disorders in two children]. [PDF]
Liao LY, Li XF, Zhang XX.
europepmc +1 more source
[POEMS syndrome misdiagnosed as systemic sclerosis: A case report]. [PDF]
Liang J, Zhang X, Yao H.
europepmc +1 more source
[Rheumatoid arthritis combined with IgG4-related disease successfully treated with rituximab: A case report]. [PDF]
Ding Y, Wang L, Li C, Lu Z, Shi L.
europepmc +1 more source
[Frontier advances in chimeric antigen receptor T cells and chimeric antigen receptor regulatory T cells therapies for autoimmune diseases]. [PDF]
Pan SA, Shi J.
europepmc +1 more source
[Guardians of Immune Tolerance: Regulatory T Cells]. [PDF]
Ming K, Zhang H, Hu H.
europepmc +1 more source
1临床资料患者,女性,54岁,因“行走不稳、言语笨拙1周”于2022年6月来本院就诊。1周前无明显诱因出现行走不稳、言语笨拙,一过性眩晕,可在他人搀扶下行走,言语笨拙类似吟诗样。既往否认饮酒史、特殊药物及毒物服用史;家族中无类似疾病病史。神经系统查体:意识水平及意识内容正常,无失语,小脑性语言,概测视野正常,双侧水平眼震,四肢肌力正常、肌张力略降低,共济失调步态,双侧指鼻试验不稳准,双侧快速轮替试验笨拙,双侧跟膝胫试验欠稳准,昂白氏征睁眼及闭眼均不稳准,左侧病理征阳性可疑,余体格检查未见明显异常。
doaj +2 more sources
[Change from Sjögren syndrome to Sjögren disease]. [PDF]
Liu Y, Shi G.
europepmc +1 more source
[A case report of primary hypomagnesemia with secondary hypocalcemia caused by <i>TRPM6</i> gene variants]. [PDF]
Zhou MY, Tang XJ, Lin SX, Chen CF.
europepmc +1 more source

